2024-02-05 05:15:09 ET
Related stock stories:
- 4D Molecular Therapeutics: Several Value Inflection Points To Watch In 2024
- Cytokinetics Steps Up As Prime Target After Aficamten's HCM Triumph (Rating Upgrade)
- Cytokinetics: Clear Win For Aficamten In SEQUOIA-HCM Phase 3 Trial (Upgrade)
- NanoString shares plunge after bankruptcy filing, weighs strategic options including possible sale
- 4DMT presents positive data from randomized phase 2 PRISM clinical trial of intravitreal 4D-150
Read the full article on Seeking Alpha
For further details see:
Biggest stock movers today: Cytokinetics, 4D Molecular Therapeutics, and more